Pediatric-onset multiple sclerosis (POMS) is characterized by high inflammatory disease activity. Our aim was to describe the treatment sequencing and report the impact highly effective disease-modifying treatment (HET) had on disease activity.

The Impact of Highly Effective Treatment in Pediatric-Onset Multiple Sclerosis: A Case Series / Immovilli, Paolo; De Mitri, Paola; Bazzurri, Veronica; Vollaro, Stefano; Morelli, Nicola; Biasucci, Giacomo; Magnifico, Fabiola; Marchesi, Elena; Lombardelli, Maria Lara; Gelati, Lorenza; Guidetti, Donata. - In: CHILDREN. - ISSN 2227-9067. - 9:11(2022), p. 1698. [10.3390/children9111698]

The Impact of Highly Effective Treatment in Pediatric-Onset Multiple Sclerosis: A Case Series

Immovilli, Paolo;Bazzurri, Veronica;Biasucci, Giacomo;Marchesi, Elena;
2022-01-01

Abstract

Pediatric-onset multiple sclerosis (POMS) is characterized by high inflammatory disease activity. Our aim was to describe the treatment sequencing and report the impact highly effective disease-modifying treatment (HET) had on disease activity.
2022
The Impact of Highly Effective Treatment in Pediatric-Onset Multiple Sclerosis: A Case Series / Immovilli, Paolo; De Mitri, Paola; Bazzurri, Veronica; Vollaro, Stefano; Morelli, Nicola; Biasucci, Giacomo; Magnifico, Fabiola; Marchesi, Elena; Lombardelli, Maria Lara; Gelati, Lorenza; Guidetti, Donata. - In: CHILDREN. - ISSN 2227-9067. - 9:11(2022), p. 1698. [10.3390/children9111698]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11381/2933079
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 2
social impact